NCT02395016 A Study of Nimotuzumab Combinated With Gemcitabine in K-RAS Wild-type Locally Advanced and Metastatic Pancreatic Cancer Status COMPLETED Phase PHASE3
NCT02393703 Interrogation of Exosome-mediated Intercellular Signaling in Patients With Pancreatic Cancer Status RECRUITING Phase N/A
NCT02368860 OXIRI [Oxaliplatin (O), Xeloda (X) and Irinotecan (I)] in Pancreatic Adenocarcinoma Status COMPLETED Phase PHASE1
NCT02366858 Comparison Between the 19 and 22 Gauge Needles for Core Tissue Procurement During EUS-guided Procedures Status WITHDRAWN Phase NA
NCT02361320 Computed Tomography in Diagnosing Patients With Pancreatic or Hepatobiliary Cancer Status RECRUITING Phase NA
NCT02358161 Phase I/II Study of LDE225 With Gemcitabine and Nab-paclitaxel in Patients With Pancreatic Cancer Status COMPLETED Phase PHASE1/PHASE2
NCT02355119 Italian Multicenter Study Comparing FOLFOXIRI Versus Gemcitabine as Adjuvant Treatment for Resected Pancreatic Cancer Status UNKNOWN Phase PHASE3
NCT02352831 Tosedostat With Capecitabine in Patients With Metastatic Pancreatic Adenocarcinoma Status TERMINATED Phase PHASE1/PHASE2
NCT02349724 A Clinical Research of CAR T Cells Targeting CEA Positive Cancer Status UNKNOWN Phase PHASE1
NCT02349412 Early Palliative Care With Standard Care or Standard Care Alone in Improving Quality of Life of Patients With Incurable Lung or Non-colorectal Gastrointestinal Cancer and Their Family Caregivers Status COMPLETED Phase PHASE3
NCT02347618 Pilot Study of Short-Course Preoperative Stereotactic Body Radiation Therapy for Resectable Pancreatic Cancer Status COMPLETED Phase NA
NCT02345408 Phase 1b Study of CCX872-B in Patients With Pancreatic Adenocarcinoma Status COMPLETED Phase PHASE1
NCT02343835 Anti-Tumor Immunity Induced by IRE of Unresectable Pancreatic Cancer Status COMPLETED Phase NA
NCT02340728 Endoscopic Biliary Co-axial Stent Placement Plus/Minus Use of Radiofrequency Ablation (RFA) for Clearance of Occluded Self Expandable Metal Stents (SEMS) in Patients With Distal Biliary Obstruction From Unresectable Biliary-pancreatic Malignancies Status COMPLETED Phase PHASE3
NCT02332863 Comparison of Back-loaded vs Preloaded Fiducial Needles in EUS-guided Fiducial Marker Placement in Pancreatic Cancer. Status COMPLETED Phase NA
NCT02331251 Study of Pembrolizumab Plus Chemotherapy in Patients With Advanced Cancer (PembroPlus) Status TERMINATED Phase PHASE1/PHASE2
NCT02329717 Efficacy and Safety Study of PBI-05204 in Patients With Stage IV Metastatic Pancreatic Adenocarcinoma Status UNKNOWN Phase PHASE2
NCT02311361 Immune Checkpoint Inhibition (Tremelimumab and/or MEDI4736) in Combination With Radiation Therapy in Patients With Unresectable Pancreatic Cancer Status COMPLETED Phase PHASE1/PHASE2
NCT02305186 Safety and Immunological Effect of Pembrolizumab in Resectable or Borderline Resectable Pancreatic Cancer Status UNKNOWN Phase PHASE1/PHASE2
NCT02295956 Preoperative Rehabilitation During Neoadjuvant Therapy for Pancreatic Cancer Status COMPLETED Phase EARLY_PHASE1